Pediatric asthma medication therapy management through community pharmacy and primary care collaboration

Bradley, Courtney L.; Luder, Heidi R.; Beck, Andrew F.; Ph.D., R.D. Phyllis E. Bowen; Heaton, Pamela C.; Kahn, Robert S.; Mansour, Mona; Obszarski, Stephen; Frede, Stacey M.

doi:10.1016/j.japh.2016.03.007

Cited by 17 publications

(48 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is recommended that every country should make updated strategies for efficient diagnosis and medicine management of asthma with an emphasis on capacity building of health professionals. The capacity building may include reinforcing the role of potential healthcare professionals and strengthening the integration of community and primary healthcare by finding innovative ways and new horizons for collaborative efforts and actions 1,2,5,6. Effective management of asthma heavily depends on the strategy of medication management to improve adherence and to avoid any medication misadventure.…”

Section: Introductionmentioning

confidence: 99%

<p>A systematic review and meta-analysis of the impact of collaborative practice between community pharmacist and general practitioner on asthma management</p>

Mubarak

Hatah

Khan

et al. 2019

JAA

View full text Add to dashboard Cite

Objective: This systematic review aims to investigate the impact of collaborative practice between community pharmacist (CP) and general practitioner (GP) in asthma management. Methods: A systematic search was performed across 10 databases (PubMed, Medline/Ovid, CINAHL, Scopus, Web of Science, Cochrane central register of controlled trials, PsycARTICLES®, Science Direct, Education Resource Information Centre, PRO-Quest), and grey literature using selected MeSH and key words, such as “community pharmacist”, “general practitioner”, and “medicine use review”. The risk of bias of the included studies was assessed by Cochrane risk of bias tool. All studies reporting any of the clinical, humanistic, and economical outcomes using collaborative practice between CPs and GPs in management of asthma, such as CPs conducting medications reviews, patient referrals or providing education and counseling, were included. Results: A total of 23 studies (six RCTs, four C-RCT, three controlled interventions, seven pre–post, and three case control) were included. In total, 11/14 outcomes were concluded in favor of CP-GP collaborative interventions with different magnitude of effect size. Outcomes, such as asthma severity, asthma control, asthma symptoms, PEFR, SABA usage, hospital visit, adherence, and quality of life (QoL) (Asthma Quality-of-Life Questionnaire [AQLQ]; Living with Asthma Questionnaire [LWAQ]) demonstrated a small effect size (d≥0.2), while inhalation technique, ED visit, and asthma knowledge witnessed medium effect sizes (ES) (d≥0.5). In addition to that, inhalation technique yielded large ES (d≥0.8) in RCTs subgroup analysis. However, three outcomes, FEV, corticosteroids usage, and preventer-to-reliever ratio, did not hold significant ES (d<0.2) and, thus, remain inconclusive. The collaboration was shown to be value for money in the economic studies in narrative synthesis, however, the limited number of studies hinder pooling of data in meta-analysis. Conclusion: The findings from this review established a comprehensive evidence base in support of the positive impact of collaborative practice between CP and GP in the management of asthma.

show abstract

Section: Introductionmentioning

confidence: 99%

<p>A systematic review and meta-analysis of the impact of collaborative practice between community pharmacist and general practitioner on asthma management</p>

Mubarak

Hatah

Khan

et al. 2019

JAA

View full text Add to dashboard Cite

show abstract

“…29 A relationship already existed between this Kroger Pharmacy and the PPCC because they previously worked together to address pediatric asthma management. 30 This relationship formed the foundation to developing a plan for improving PNA within this clinic population.…”

Section: Resultsmentioning

confidence: 99%

Addressing primary nonadherence: A collaboration between a community pharmacy and a large pediatric clinic

Hackerson¹,

Luder²,

Beck³

et al. 2018

Journal of the American Pharmacists Association

Self Cite

View full text Add to dashboard Cite

show abstract

“…Specialty groups, such as the Childhood Arthritis and Rheumatology Research Alliance in North America and others focused on outpatient chronic care management, afford another potential network arrangement for pharmacist-pediatrician collaboration [90,91]. In a pilot study, collaboration between a community pharmacy and local pediatric primary care centers targeted asthma, a major chronic disease in children [92].…”

Section: Network Design Requirements and Electronic Health Record mentioning

confidence: 99%

Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective

et al. 2019

View full text Add to dashboard Cite

Children with special health care needs (CSHCN) use relatively high quantities of healthcare resources and have overall higher morbidity than the general pediatric population. Embedding clinical pharmacists into the Patient-Centered Medical Home (PCMH) to provide comprehensive medication management (CMM) through collaborative practice agreements (CPAs) for children, especially for CSHCN, can improve outcomes, enhance the experience of care for families, and reduce the cost of care. Potential network infrastructures for collaborative practice focused on CSHCN populations, common language and terminology for CMM, and clinical pharmacist workforce estimates are provided. Applying the results from the CMM in Primary Care grant, this paper outlines the following: (1) setting up collaborative practices for CMM between clinical pharmacists and pediatricians (primary care pediatricians and sub-specialties, such as pediatric clinical pharmacology); (2) proposing various models, organizational structures, design requirements, and shared electronic health record (EHR) needs; and (3) outlining consistent documentation of CMM by clinical pharmacists in CSHCN populations.

show abstract

Pediatric asthma medication therapy management through community pharmacy and primary care collaboration

Cited by 17 publications

References 17 publications

<p>A systematic review and meta-analysis of the impact of collaborative practice between community pharmacist and general practitioner on asthma management</p>

<p>A systematic review and meta-analysis of the impact of collaborative practice between community pharmacist and general practitioner on asthma management</p>

Addressing primary nonadherence: A collaboration between a community pharmacy and a large pediatric clinic

Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective

Contact Info

Product

Resources

About